dc.contributor.author | Søgaard, Caroline Danielsen | |
dc.contributor.author | Moestue, Siver Andreas | |
dc.contributor.author | Rye, Morten Beck | |
dc.contributor.author | Kim, Jana | |
dc.contributor.author | Nepal, Anala | |
dc.contributor.author | Liabakk, Nina-Beate | |
dc.contributor.author | Bachke, Siri | |
dc.contributor.author | Bathen, Tone Frost | |
dc.contributor.author | Otterlei, Marit | |
dc.contributor.author | Hill, Deborah Katherine | |
dc.date.accessioned | 2019-03-23T21:50:38Z | |
dc.date.available | 2019-03-23T21:50:38Z | |
dc.date.created | 2017-11-10T10:43:11Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Søgaard, C. D., Moestue, S. A., Rye, M. B., Kim, J., Nepal, A., Liabakk, N.-B., ... Hill, D. K. (2018). APIM-peptide targeting PCNA improves the efficacy of docetaxel treatment in the TRAMP mouse model of prostate cancer. OncoTarget, 9(14), 11752-11766. doi: | nb_NO |
dc.identifier.issn | 1949-2553 | |
dc.identifier.uri | http://hdl.handle.net/11250/2591427 | |
dc.language.iso | eng | nb_NO |
dc.publisher | Impact Journals LLC | nb_NO |
dc.rights | Navngivelse 4.0 Internasjonal | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/deed.no | * |
dc.title | APIM-peptide targeting PCNA improves the efficacy of docetaxel treatment in the TRAMP mouse model of prostate cancer | nb_NO |
dc.type | Journal article | nb_NO |
dc.type | Peer reviewed | nb_NO |
dc.description.version | publishedVersion | nb_NO |
dc.rights.holder | © 2018, The Author(s) | nb_NO |
dc.subject.nsi | VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Onkologi: 762 | nb_NO |
dc.source.pagenumber | 11752-11766 | nb_NO |
dc.source.volume | 9 | nb_NO |
dc.source.journal | OncoTarget | nb_NO |
dc.source.issue | 14 | nb_NO |
dc.identifier.doi | 10.18632/oncotarget.24357 | |
dc.identifier.cristin | 1512870 | |
dc.relation.project | Norges forskningsråd: 239940 | nb_NO |